CartiHeal Ltd.

Bioventus is exercising its option to buy Cartiheal and plans to launch Cartiheal’s Agili-C knee implant in the third quarter. Agili-C is a porous, biodegradable scaffold for treating cartilage and

The global market for orthobiologics for musculoskeletal soft tissue replacement and regeneration is expected to reach $2.3bn by 2023, with a compound annual growth rate (CAGR) of 4.0%, according to "

The global market for orthobiologic products used in musculoskeletal soft tissue replacement and regeneration is expected to expand at a compound annual growth rate of 5.9% to reach $1.4bn by 2021. Ac

Device Transactions During the first quarter of 2016, device companies raised an aggregate $1.8 billion in financing, a 50% increase over last quarter's $1.2 billion. Debt was the top financing vehicl